Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Carcinoid Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00884715
What this trial is testing

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Endo USA Inc., a Keenova Therapeutics Company 10
Not applicableActive Not RecruitingNCT03498040
What this trial is testing

Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

Who this might be right for
Carcinoid Heart Disease
Hospices Civils de Lyon 670
Post-approval studies (Phase 4)Ended earlyNCT04140409
What this trial is testing

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Very early researchActive Not RecruitingNCT04993261
What this trial is testing

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Who this might be right for
Carcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more
M.D. Anderson Cancer Center 71
Large-scale testing (Phase 3)Study completedNCT00774930
What this trial is testing

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 115
Not applicableStudy completedNCT03223428
What this trial is testing

Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO

Who this might be right for
Carcinoid Syndrome
TerSera Therapeutics LLC 223
Not applicableActive Not RecruitingNCT05064514
What this trial is testing

Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease

Who this might be right for
Tricuspid RegurgitationTricuspid Valve DiseaseCarcinoid Syndrome+1 more
Queen Mary University of London 15
Large-scale testing (Phase 3)WithdrawnNCT04065165
What this trial is testing

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome

Who this might be right for
Small Intestinal NETCarcinoid Heart Disease
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableNot Yet RecruitingNCT07450287
What this trial is testing

CardioNETPOL National Registry of Carcinoid Heart Disease

Who this might be right for
Carcinoid Heart DiseaseNeuroendocrine TumorsCarcinoid Syndrome+1 more
National Institute of Cardiology, Warsaw, Poland 120
Early research (Phase 1)Study completedNCT01932528
What this trial is testing

An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 8
Not applicableStudy completedNCT01430871
What this trial is testing

Effects of Serotonin Excess on Bone in Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Sheffield Teaching Hospitals NHS Foundation Trust 52
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT03722511
What this trial is testing

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Who this might be right for
Neuroendocrine TumorsCarcinoid Tumor of GI SystemDiarrhea+1 more
Lowell Anthony, MD 10
Not applicableStudy completedNCT03220087
What this trial is testing

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

Who this might be right for
Neuroendocrine Tumors
Ipsen 142
Testing effectiveness (Phase 2)WithdrawnNCT04713202
What this trial is testing

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl

Who this might be right for
Neuroendocrine TumorsCarcinoid SyndromeDiarrhea
Chandrikha Chandrasekhara
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT00088595
What this trial is testing

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Who this might be right for
Carcinoid Tumors
Novartis Pharmaceuticals 45
Not applicableStudy completedNCT00789841
What this trial is testing

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor
University of Aarhus 13
Testing effectiveness (Phase 2)Study completedNCT01104415
What this trial is testing

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 15
Next Page